Sampre Nutritions Ltd

Sampre Nutritions Ltd has demonstrated a notable improvement in its financial performance for the quarter ended June 2026, signalling a shift from a very positive to a positive financial trend. Despite this quarter’s encouraging revenue growth and margin stability, the company continues to face significant headwinds reflected in its long-term stock returns and micro-cap status within the FMCG sector.

Sampre Nutritions Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 01 June 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 05 August 2026, providing investors with the latest insights into the company’s fundamentals, valuation, financial trends, and technical outlook.

For the fifth consecutive session, Sampre Nutritions Ltd closed lower, slipping to a fresh 52-week low of Rs 4.51 on 4 Aug 2026, marking a steep decline of 67.02% over the past year despite a broader market that has largely held steady.

Sampre Nutritions Ltd’s share price declined to a fresh 52-week low of Rs.4.9 on 03 Aug 2026, marking a significant downturn amid broader market fluctuations. The stock’s performance continues to trail its sector and benchmark indices, reflecting ongoing concerns about its financial metrics and valuation.

For the eighth consecutive session, Sampre Nutritions Ltd has closed lower, culminating in a fresh 52-week low of Rs 4.92 on 31 Jul 2026. This sustained decline has dragged the stock down by 31% over this period, sharply underperforming its FMCG sector peers and the broader market indices.

For the seventh consecutive session, Sampre Nutritions Ltd has closed lower, culminating in a fresh 52-week low of Rs 5.17 on 30 Jul 2026. This marks a steep 27.49% decline over the past week, extending the stock’s downward trajectory amid broader market stability.

For the sixth consecutive session, Sampre Nutritions Ltd has closed lower, culminating in a fresh 52-week low of Rs 5.44 on 29 Jul 2026. This marks a steep 23.7% decline over the past six days, underscoring persistent selling pressure despite a broadly rising market backdrop.

Sampre Nutritions Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 01 June 2026. However, the analysis and financial metrics presented here reflect the stock’s current position as of 21 July 2026, providing investors with the most recent insights into the company’s performance and outlook.

For the eighth consecutive session, Sampre Nutritions Ltd has closed lower, culminating in a fresh 52-week low of Rs 5.55 on 13 Jul 2026. This sustained decline has dragged the stock down by 28.21% over this period, sharply underperforming its FMCG sector peers and the broader market indices.

For the seventh consecutive session, Sampre Nutritions Ltd has closed lower, culminating in a fresh 52-week low of Rs 5.84 on 10 Jul 2026. This marks a steep 26.09% decline over the past week, sharply underperforming its FMCG sector peers and the broader market indices.

For the sixth consecutive session, Sampre Nutritions Ltd has closed lower, culminating in a fresh 52-week low of Rs 6.14 on 9 Jul 2026, marking a near 20% decline over this period amid broader market gains.

Sampre Nutritions Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 01 June 2026. However, the analysis and financial metrics discussed below reflect the stock's current position as of 09 July 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance.

For the fifth consecutive session, Sampre Nutritions Ltd closed lower, slipping to a fresh 52-week low of Rs 6.46 on 8 Jul 2026. This marks an 18.35% decline over the past five days, extending the stock’s downward trajectory amid broader market weakness.

For the fourth consecutive session, Sampre Nutritions Ltd has seen its share price decline, culminating in a fresh 52-week low of Rs 6.82 on 7 Jul 2026. This marks an 11.49% drop over the past four days, underscoring persistent selling pressure despite broader market gains.

For the third consecutive session, Sampre Nutritions Ltd has closed lower, slipping to a fresh 52-week low of Rs 7.13 on 6 Jul 2026, marking an 8.49% decline over this period despite a broadly rising market backdrop.

A sharp decline has pushed Sampre Nutritions Ltd to a fresh 52-week low of Rs 7.3 on 30 Jun 2026, marking a significant drop from its 52-week high of Rs 42.33. Despite recent positive quarterly earnings, the stock continues to face downward pressure amid broader market volatility and company-specific concerns.

Sampre Nutritions Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 01 June 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 28 June 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance.

Sampre Nutritions Ltd’s stock price declined sharply to a fresh 52-week low of Rs.7.33 on 23 June 2026, marking a significant milestone in its ongoing downward trajectory. The stock has underperformed its sector and broader market indices, reflecting a series of challenges impacting investor sentiment and market valuation.